
Investors should consider a long position in Meta Platforms (META), as its massive distribution and AI leadership under Alex Wang make the stock appear undervalued. Roblox (RBLX) is identified as a high-conviction growth play with "double" potential due to 40% revenue growth, though investors must monitor high stock dilution. In the biotech sector, Spruce Biosciences (SPRB) is highlighted as a speculative opportunity with 10X potential for those with a high risk tolerance. Conversely, the semiconductor sector is viewed as a "bubble," making Intel (INTC) a primary short candidate and SanDisk a high-risk, small-sized short for experienced traders. Avoid long-term exposure to Novo Nordisk (NVO) due to looming patent expirations for Ozempic, and remain cautious of Google (GOOGL) as potential disappointment in its TPU hardware could trigger a reversal.
• The speaker expresses extreme bearishness on the semiconductor sector, labeling the current market as "peak cyclomania." • Micron (MU) and SanDisk are highlighted as being at the top of a "blow-off top." The speaker notes that at peak cycle, these companies typically trade at 5x earnings, but current valuations (e.g., Micron at a $700 billion market cap) are viewed as irrational. • Intel (INTC) is specifically called out as a short opportunity.
• Bearish Sentiment: The speaker believes the "top is in" for hardware and semiconductors. • Actionable Trade: Suggests starting a "small" short position in SanDisk, but warns it is a "widowmaker" trade and should be kept to a tiny position (10 basis points). • Risk Factor: Acknowledges that his "old boss" (referred to as a semi’s genius) is actually long and bullish, suggesting a high level of conflict in professional opinions.
• The speaker suggests that Google might be a good short candidate at current levels. • The primary concern is that TPUs (Tensor Processing Units) will likely disappoint the market's high expectations.
• Short Thesis: Potential disappointment in proprietary AI hardware (TPUs) could lead to a reversal of the recent rally.
• The speaker is a self-proclaimed "Zuck fanboy" and remains bullish on the company’s long-term prospects. • Alex Wang (from Scale AI) is noted as a key hire leading the AI team; the speaker believes Wang is a "business genius" who will help Meta productize AI effectively. • Despite high R&D spending, the speaker notes Meta still has strong net cash and retained earnings.
• Bullish Sentiment: Meta is viewed as "still cheap" with a massive distribution advantage that will allow them to win in the AI space by making technology accessible to billions.
• Described as "growing like a weed" with revenue growth around 40%. • The speaker identifies a disconnect between the company's cash flow and its market perception, calling it an "easy double."
• Investment Insight: Viewed as a strong long-term growth play despite current unprofitability. • Risk Factor: High levels of stock dilution and increasing share count are noted as significant negatives.
• Mentioned as "getting hosed" and reaching session lows despite a "big quarter." • The speaker finds the downward price action "very weird" given the growth profile.
• Sentiment: Neutral to Bullish on fundamentals, but cautious due to the stock's high volatility and current downward momentum.
• The speaker is heavily involved in this company and is personally long. • The goal is to build the "world's first photonic computer," which could solve GPU bottlenecks. • It is noted as a long-term play (10-year horizon), similar to the timeline for quantum computing.
• Investment Theme: Photonic computing is identified as a potential successor to current GPU technology. • Risk Factor: Expect significant dilution, as is standard for hardware startups.
• Biohaven: Mentioned as a long-term "management pick." • SPRB: The speaker maintains a bullish stance, suggesting it has 10X potential, noting that the core opportunity hasn't changed despite market fluctuations.
• Sentiment: Bullish on both as speculative or management-led biotech plays.
• The speaker views the business as "complicated." • A major long-term risk identified is that Ozempic will eventually go generic, which is cited as the company's biggest problem.
• Risk Factor: Long-term patent expiration and generic competition for GLP-1 drugs.
• The speaker notes a divergence in valuations: Software stocks are generally not considered expensive right now, while Hardware is viewed as being in a massive bubble.
• The speaker describes value investing as "tragic" and "painful" in the current environment. • Insight: Value investors look "stupid" during growth cycles but "geniuses" when the cycle turns. He cites PayPal (PYPL) as an example of a value trap where investors are currently taking a lot of pain.
• Strategy: The speaker mentions that shorting small caps can be a way to make money but explicitly warns the general public: "Don't do shorting small caps." It is implied to be too risky for non-professional traders.

By @realmartinshkreli
Investing, music, science, math, technology, programming, medicine and more!